Kristin Rentzsch Selected Research

AMPA 3 glutamate receptor ionotropic

1/2021

Case Report: Semantic Variant of Primary Progressive Aphasia Associated With Anti-Glial Fibrillary Acid Protein Autoantibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kristin Rentzsch Research Topics

Disease

6	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 10/2015 - 08/2012
2	Cognitive Dysfunction 12/2021 - 09/2021
2	Brain Injuries (Brain Injury) 01/2021 - 05/2015
2	Frontotemporal Dementia (Semantic Dementia) 01/2021 - 01/2017
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2017 - 08/2012
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2022
1	Mood Disorders (Mood Disorder) 01/2022
1	Delirium 01/2022
1	Ataxia (Dyssynergia) 12/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2021
1	Lung Neoplasms (Lung Cancer) 09/2021
1	Memory Disorders (Memory Loss) 09/2021
1	Primary Progressive Aphasia 01/2021
1	Bullous Pemphigoid (Pemphigoid) 05/2019
1	Polyneuropathies (Polyneuropathy) 05/2019
1	Pemphigus (Pemphigus Vulgaris) 12/2017
1	Prodromal Symptoms 01/2017
1	Disease Progression 01/2017
1	Inflammation (Inflammations) 01/2017
1	Autoimmune Diseases of the Nervous System 10/2016
1	Neuromyelitis Optica (Devic's Disease) 01/2016
1	Stroke (Strokes) 05/2015
1	Ischemic Stroke 05/2015
1	Autoimmune Diseases (Autoimmune Disease) 07/2014
1	Autoimmune Hepatitis 01/2013
1	Liver Diseases (Liver Disease) 01/2013
1	Sarcoma (Soft Tissue Sarcoma) 08/2012

Drug/Important Bio-Agent (IBA)

10	AutoantibodiesIBA 01/2022 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 03/2013
3	poly(glycyl-alanyl)IBA 01/2017 - 10/2014
2	AntibodiesIBA 12/2021 - 01/2016
2	DipeptidesIBA 10/2014 - 03/2013
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	RecoverinIBA 12/2021
1	AntigensIBA 09/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2021
1	AMPA 3 glutamate receptor ionotropicIBA 01/2021
1	AcidsIBA 01/2021
1	Glial Fibrillary Acidic ProteinIBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 05/2019
1	EpitopesIBA 05/2019
1	DesmocollinsIBA 12/2017
1	DesmogleinsIBA 12/2017
1	Protein Isoforms (Isoforms)IBA 12/2017
1	Surface Antigens (Surface Antigen)IBA 10/2016
1	AutoantigensIBA 10/2016
1	Aquaporins (Water Channels)IBA 01/2016
1	Apolipoprotein E4IBA 05/2015
1	Indicators and Reagents (Reagents)IBA 05/2015
1	NMDA receptor A1IBA 05/2015
1	N-glycylalanine (Gly-Ala)IBA 10/2014
1	Monoclonal AntibodiesIBA 12/2013
1	ProgranulinsIBA 05/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2013
1	DNA Methyltransferase 3AIBA 05/2013
1	Recombinant ProteinsIBA 01/2013
1	liver antigen LA-1IBA 01/2013
1	Nuclear Proteins (Protein, Nuclear)IBA 08/2012

Therapy/Procedure

1	Immunotherapy 10/2016
1	Drug Therapy (Chemotherapy) 05/2013